Is PRCT a good stock to buy?
We came across a bullish thesis on PROCEPT BioRobotics Corporation on r/ValueInvesting by mrmrmrj
In this article, we will summarize the bulls’ thesis on PRCT. PROCEPT BioRobotics Corporation’s share was trading at $20.91 as of June 17th. Master Video/ Procept BioRobotics (PRCT) is a high-growth surgical robotics company with rapid revenue scaling and expanding gross margins, with revenues having quadrupled since 2022, indicating early-stage economies of scale similar to leading medtech robotics peers.
The company’s current operating base is benchmarked against Intuitive Surgical (ISRG), where ISRG in mid-2006 had crossed roughly a similar ~$300 million revenue threshold, comparable gross margins, and a significantly larger capital base, yet traded through a volatile 9–18x sales multiple range. 15 AI Stocks That Are Quietly Making Investors Rich Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential By contrast, PRCT currently trades at approximately 4.5x sales despite growing faster at a similar developmental stage, creating a notable valuation gap relative to historical ISRG execution. If PRCT continues to replicate ISRG’s trajectory, multiple expansion and revenue growth could drive substantial equity upside, with potential ~150% appreciation over a three-year horizon driven by revenue compounding and re-rating. Near-term sentiment is mixed due to management guiding revenue slightly below expectations, although still reflecting ~30% year-over-year growth, which introduces short-term skepticism.